SureTrader SureTrader
Home > Boards > Free Zone > User's Groups >

ImmunoTrend

RSS Feed
      Hide Sticky   Hide Intro
Moderator: No Moderator Assistants: Habitual
Search This Board:
Last Post: 6/21/2016 11:32:35 PM - Followers: 1 - Board type: Free - Posts Today: 0
immunotrend will explore the many new therapies being developed for the understanding of the biology that controls both disease and lifespan.
PostSubject
#10   http://www.onclive.com/web-exclusives/emerging-immunotherapy-target-in-spotlight Habitual 06/21/16 11:32:35 PM
#9   http://www.news-medical.net/news/20150530/Inhibitors-BGB324-and-BGB10C9-show-pro Habitual 06/14/15 10:11:24 PM
#8   Use of Autoantigen-Loaded Phosphatidylserine-Liposomes to Arrest Autoimmunity in Habitual 06/14/15 10:00:03 PM
#7   Imaging and Therapy of Pancreatic Cancer with Phosphatidylserine-Targeted Habitual 06/14/15 09:59:08 PM
#6   Necrotic Cells Actively Attract Phagocytes through the Collaborative Habitual 06/14/15 09:50:25 PM
#5   Unquenchable Surface Potential Dramatically Enhances Cu(2+) Binding to Habitual 06/14/15 09:48:40 PM
#4   FDA Approves First Immunotherapy for Children With Cancer Habitual 03/19/15 10:20:44 AM
#3   Non-small cell lung cancer (NSCLC) is characterized by Habitual 03/19/15 09:03:10 AM
#2   Curis will be developing small-molecule compounds that can Habitual 01/23/15 05:38:32 PM
#1   This board was started to advance discussions regarding Habitual 09/23/14 06:15:09 PM
PostSubject